REFERENCES
1. Campbell L, Zirwas MJ. Triclosan. Dermatitis.2006;17(4):204-207.
2. McNamara PJ, Levy SB. Triclosan: an Instructive Tale.Antimicrob Agents Chemother. 2016;60(12):7015-7016.
3. Halden RU, Lindeman AE, Aiello AE, et al. The Florence Statement on Triclosan and Triclocarban. Environ Health Perspect.2017;125(6):064501.
4. Dann AB, Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol. 2011;31(4):285-311.
5. Sinicropi MS, Iacopetta D, Ceramella J, et al. Triclosan: A Small Molecule with Controversial Roles. Antibiotics (Basel).2022;11(6).
6. Wang CF, Tian Y. Reproductive endocrine-disrupting effects of triclosan: Population exposure, present evidence and potential mechanisms. Environ Pollut. 2015;206:195-201.
7. Food and Drug Adminnistration HHS. Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule. Fed Regist.2016;81(172):61106-61130.
8. Edmiston CE, Seabrook GR, Goheen MP, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg. 2006;203(4):481-489.
9. Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt). 2004;5(3):281-288.
10. Ming X, Rothenburger S, Yang D. In vitro antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan).Surg Infect (Larchmt). 2007;8(2):201-208.
11. Marco F, Vallez R, Gonzalez P, Ortega L, de la Lama J, Lopez-Duran L. Study of the efficacy of coated Vicryl plus antibacterial suture in an animal model of orthopedic surgery. Surg Infect (Larchmt).2007;8(3):359-365.
12. Storch M, Perry LC, Davidson JM, Ward JJ. A 28-day study of the effect of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect (Larchmt). 2002;3 Suppl 1:S89-98.
13. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays.Surg Infect (Larchmt). 2002;3 Suppl 1:S79-87.
14. Storch M, Scalzo H, Van Lue S, Jacinto G. Physical and functional comparison of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) with Coated VICRYL* Suture (coated polyglactin 910 suture). Surg Infect (Larchmt). 2002;3 Suppl 1:S65-77.
15. Seim BE, Tønnessen T, Woldbaek PR. Triclosan-coated sutures do not reduce leg wound infections after coronary artery bypass grafting.Interact Cardiovasc Thorac Surg. 2012;15(3):411-415.
16. Turtiainen J, Saimanen EI, Mäkinen KT, et al. Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg. 2012;36(10):2528-2534.
17. Mattavelli I, Rebora P, Doglietto G, et al. Multi-Center Randomized Controlled Trial on the Effect of Triclosan-Coated Sutures on Surgical Site Infection after Colorectal Surgery. Surg Infect (Larchmt).2015;16(3):226-235.
18. Thimour-Bergström L, Roman-Emanuel C, Scherstén H, Friberg Ö, Gudbjartsson T, Jeppsson A. Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: a randomized controlled trial. Eur J Cardiothorac Surg. 2013;44(5):931-938.
19. Sprowson AP, Jensen CD, Parsons N, et al. The effect of triclosan coated sutures on rate of surgical site infection after hip and knee replacement: a protocol for a double-blind randomised controlled trial.BMC Musculoskelet Disord. 2014;15:237.
20. Chang WK, Srinivasa S, Morton R, Hill AG. Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg.2012;255(5):854-859.
21. Wang ZX, Jiang CP, Cao Y, Ding YT. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2013;100(4):465-473.
22. Ahmed I, Boulton AJ, Rizvi S, et al. The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature. BMJ Open. 2019;9(9):e029727.
23. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784-791.
24. Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e288-e303.
25. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017;224(1):59-74.
26. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414-419.
27. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001-1006.
28. Honda T, Egawa G, Grabbe S, Kabashima K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol.2013;133(2):303-315.
29. Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol.2012;12(2):114-124.
30. Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy.2009;64(12):1699-1714.
31. Scheinman PL, Vocanson M, Thyssen JP, et al. Contact dermatitis.Nat Rev Dis Primers. 2021;7(1):38.
32. Garg V, Brod B, Gaspari AA. Patch testing: Uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol. 2021;39(4):580-590.
33. Perrenoud D, Bircher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis.1994;30(5):276-279.
34. Buhl T, Fuchs T, Geier J. Contact hypersensitivity to triclosan.Ann Allergy Asthma Immunol. 2014;113(1):119-120.
35. Robertshaw H, Leppard B. Contact dermatitis to triclosan in toothpaste. Contact Dermatitis. 2007;57(6):383-384.
36. Roed-Petersen J, Auken G, Hjorth N. Contact sensitivity to Irgasan DP 300. Contact Dermatitis. 1975;1(5):293-294.
37. Wong CS, Beck MH. Allergic contact dermatitis from triclosan in antibacterial handwashes. Contact Dermatitis. 2001;45(5):307.
38. Steinkjer B, Braathen LR. Contact dermatitis from triclosan (Irgasan DP 300). Contact Dermatitis. 1988;18(4):243-244.
39. Zaugg T, Hunziker T. Germall II and triclosan. Contact Dermatitis. 1987;17(4):262.
40. Veronesi S, de Padova MP, Vanni D, Melino M. Contact dermatitis to triclosan. Contact Dermatitis. 1986;15(4):257-258.
41. Ismail FF, Nixon R. Allergic contact dermatitis to triclosan-coated suture material. Contact Dermatitis. 2020;82(5):330-331.
42. Holzheimer RG. Adverse events of sutures: possible interactions of biomaterials? Eur J Med Res. 2005;10(12):521-526.
43. Bhutani T, Jacob SE. Triclosan: a potential allergen in suture-line allergic contact dermatitis. Dermatol Surg. 2009;35(5):888-889.
44. Pierannunzii L, Fossali A, De Lucia O, Guarino A. Suture-related pseudoinfection after total hip arthroplasty. J Orthop Traumatol.2015;16(1):59-65.
45. Schalock PC, Dunnick CA, Nedorost S, Brod B, Warshaw E, Mowad C. American Contact Dermatitis Society Core Allergen Series: 2017 Update.Dermatitis. 2017;28(2):141-143.
46. Zhu TH, Suresh R, Warshaw E, et al. The Medical Necessity of Comprehensive Patch Testing. Dermatitis. 2018;29(3):107-111.
47. Uyesugi BA, Sheehan MP. Patch Testing Pearls. Clin Rev Allergy Immunol. 2019;56(1):110-118.
48. Bruze M, Condé-Salazar L, Goossens A, Kanerva L, White IR. Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis. Contact Dermatitis. 1999;41(5):241-250.
49. Andersen KE, Andersen F. The reaction index and positivity ratio revisited. Contact Dermatitis. 2008;58(1):28-31.
50. Kahwash BM, Schalock PC. In vivo evaluation of allergic contact dermatitis to nylon suture: A case report. Contact Dermatitis.2022;87(1):116-118.
51. Ogbechie OA, Paul S, Schalock PC. A technique for identifying vicryl suture hypersensitivity. Dermatitis. 2014;25(6):370-371.
52. Fisher AA. Nylon allergy: nylon suture test. Cutis.1994;53(1):17-18.
53. Ethicon Product Catalog. In:2019:233.
54. Bashir SJ, Maibach HI. Compound allergy. An overview. Contact Dermatitis. 1997;36(4):179-183.
55. Sayegh S, Bernard L, Stern R, Pache JC, Szalay I, Hoffmeyer P. Suture granuloma mimicking infection following total hip arthroplasty. A report of three cases. J Bone Joint Surg Am.2003;85(10):2006-2009.
56. Stocco C, Berton F, Papa G, Bussani R, Arnež ZM. Vicryl Hypersensitivity Test With Histological Response. Dermatitis.2016;27(3):145-146.
57. Garg N, Moorthy N. A mysterious pacemaker suture: an uncommon foreign body reaction. Indian Pacing Electrophysiol J.2011;11(1):27-30.
58. Al-Qattan MM, Kfoury H. A Delayed Allergic Reaction to Polypropylene Suture Used in Flexor Tendon Repair: Case Report. J Hand Surg Am.2015;40(7):1377-1381.